Mr. Wood has been ESSA’s Chief Financial Officer since 2013. Mr. Wood has over 30 years of experience in management of both early and late stage companies in North America and the U.K. and has over 18 years of experience in the biopharmaceutical industry, where he has overseen several M&A transactions and numerous financings. Prior to joining ESSA, Mr. Wood was Head of Finance, Secretary and Treasurer at Celator Pharmaceuticals Inc., now a subsidiary of Jazz Pharmaceuticals. Previously, Mr. Wood was a Managing Director of Cubist Pharmaceuticals (UK) Ltd. and Finance Director at TerraGen Discovery, Inc. Mr. Wood began his career in the finance and exploration departments of Chevron Corp. He received a B.Sc. in Biology from Queen’s University, an M.B.A. from University of Western Ontario and holds a CPA, CMA accounting designation.

• 

  CFO: Chief Financial Officer in ESSA Pharmaceuticals

  Developing the Next Generation of Treatments for Prostate Cancer